Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance
Open Access
- 1 April 2004
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (4) , 861-868
- https://doi.org/10.2337/diacare.27.4.861
Abstract
OBJECTIVE—Previous reports of an association between low testosterone levels and diabetes risk were often confounded by covariation of sex hormone-binding globulin (SHBG) and testosterone measurements. Measurements of bioavailable and free testosterone, more reliable indexes of biologically active testosterone, were examined for their associations with markers of insulin resistance and body fat measures in 221 middle-aged nondiabetic men. RESEARCH DESIGN AND METHODS—Bioavailable and free testosterone were calculated from the concentrations of total testosterone, SHBG, and albumin, and they were not significantly correlated with SHBG (r = 0.07–0.1). In contrast, total testosterone correlated significantly with SHBG (r = 0.63). We evaluated the relationship between these measures of circulating testosterone and markers for insulin resistance (i.e., fasting insulin, C-peptide, and homeostasis model assessment for insulin resistance [HOMA-IR]) as well as total body fat (assessed by dual-energy X-ray absorptiometry [DEXA]) and abdominal fat distribution (assessed by single-slice computed tomography [CT]). RESULTS—Bioavailable, free, and total testosterone and SHBG all correlated significantly with fasting insulin (age-adjusted r = −0.15 [P = 0.03], −0.14 [P = 0.03], −0.32 [P < 0.0001], and −0.38 [P < 0.0001], respectively), fasting C-peptide (r = −0.18 [P = 0.009] to −0.41 [P < 0.0001]), HOMA-IR (r = −0.15 [P = 0.03] to − 0.39 [P < 0.0001]), and body fat measures (r = −0.17 [P = 0.008] to −0.44 [P < 0.0001]). Only SHBG and total testosterone were significantly associated with fasting glucose (r = −0.20 [P = 0.003] to −0.21 [P = 0.002]). In multivariate analysis, bioavailable or free testosterone was significantly and inversely associated with insulin, C-peptide, and HOMA-IR, but this was not independent of total body or abdominal fat. SHBG was a significant determinant of insulin, C-peptide, and HOMA-IR, independent of body fat. The associations between total testosterone and insulin resistance were confounded by SHBG. CONCLUSIONS—The inverse association between testosterone and insulin resistance, independent of SHBG, was mediated through body fat.Keywords
This publication has 39 references indexed in Scilit:
- Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperaturePublished by Elsevier ,2003
- The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young MenJournal of Clinical Endocrinology & Metabolism, 2002
- Low serum testosterone level as a predictor of increased visceral fat in Japanese-American menInternational Journal of Obesity, 2000
- A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in SerumJournal of Clinical Endocrinology & Metabolism, 1999
- Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese malesJournal of Clinical Endocrinology & Metabolism, 1996
- Relation of Steroid Hormones to Glucose Tolerance and Plasma Insulin Levels in Men: Importance of visceral adipose tissueDiabetes Care, 1995
- Insulin resistance, body fat distribution, and sex hormones in menDiabetes, 1994
- Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in menJournal of Clinical Endocrinology & Metabolism, 1993
- Lower endogenous androgens predict central adiposity in menAnnals of Epidemiology, 1992
- Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men.Journal of Clinical Investigation, 1987